Patients frequently experience a loss of salivary function following irradiation (IR) for the treatment of an oral cavity and oropharyngeal cancer. Herein, we tested if transfer of fibroblast growth factor-2 (FGF2) cDNA could limit salivary dysfunction after fractionated IR (7.5 or 9 Gy for 5 consecutive days to one parotid gland) in the miniature pig (minipig). Parotid salivary flow rates steadily decreased by 16 weeks post-IR, whereas blood flow in the targeted parotid gland began to decrease~3 days after beginning IR. By 2 weeks, post-IR salivary blood flow was reduced by 50%, at which point it remained stable for the remainder of the study. The single preadministration of a hybrid serotype 5 adenoviral vector encoding FGF2 (AdLTR 2 EF1a-FGF2) resulted in the protection of parotid microvascular endothelial cells from IR damage and significantly limited the decline of parotid salivary flow. Our results suggest that a local treatment directed at protecting salivary gland endothelial cells may be beneficial for patients undergoing IR for oral cavity and oropharyngeal cancer.
INTRODUCTION
The American Cancer Society estimated that 170 900 new cases of oral cavity and oropharyngeal cancer were diagnosed in the world in 2011. 1 For most such patients, treatment includes irradiation (IR), with consequent damage to the major salivary glands present in the IR field. As a result, most surviving oral and oropharyngeal cancer patients suffer significant losses in salivary flow and considerable morbidity, including xerostomia, dysphagia and oral infections, 2, 3 resulting in a significantly reduced quality of life. 4 Advances in the delivery of IR have helped somewhat in reducing the severity of salivary gland damage (e.g., intensity-modulated radiotherapy). [5] [6] [7] Additionally, related procedures such as surgical translocation of submandibular glands into the sublingual space and the use of pharmaceutical agents during IR can help reduce, but not eliminate, IR-induced gland damage. [8] [9] [10] [11] There remains no satisfactory conventional means for preventing IR-induced salivary hypofunction.
Our previous studies have shown that while not identical to human parotid glands, miniature pig (minipig) parotid glands do share several anatomic and physiologic characteristics with human glands and provide a valuable and affordable large animal model for studying IR-induced salivary hypofunction. 12, 13 Indeed, for many years we have used this model to develop a novel, gene transfer-based corrective treatment for existing IR-induced salivary hypofunction, 14 using the human aquaporin-1 (hAQP1) cDNA 15 encoded within either a serotype 5 adenoviral vector (AdhAQP1) 16, 17 or a serotype 2 adeno-associated viral vector (AAV2hAQP1). 18 We recently completed a phase I clinical trial with AdhAQP1, which led to increased parotid flow and symptom relief in a subset of patients. 19 However, while AdhAQP1 delivery for IR-induced salivary hypofunction is potentially therapeutic, it does not prevent the IR-induced gland damage.
Previously, we showed in mice and minipig that salivary gland microvascular density (MVD) declined from 4 to 24 h postsingle dose IR and remained below control levels. 20, 21 In mice, we also showed that pretreatment with a first-generation adenoviral vector encoding the fibroblast growth factor-2 (FGF2) cDNA protected microvascular endothelial cells from IR damage and preserved salivary flow rates. 20 Herein, we evaluated this same strategy in a large animal model using a modified hybrid serotype 5 adenoviral vector encoding the FGF2 cDNA (AdLTR 2 EF1α-FGF2). We found that this strategy protected minipig parotid microvascular endothelial cells from IR damage and limited the decline of parotid salivary flow rates.
RESULTS

Effects of parotid gland irradiation
Initially, we examined the effects of fractionated IR to the parotid glands of 12 minipigs (n = 4 per group). There was no significant difference in parotid flow rates between control animals and animals in both IR-treated dose groups before the start of this study (mean ± s.d.: 2859 ± 209 μl 10 min , 9 Gy per day group; analysis of variance (ANOVA) was not significant). Saliva flow rates in all irradiated glands steadily diminished following IR. By 16 weeks after the 7.5 Gy per day dose, there was an~60% reduction in the salivary flow rate from the targeted 1 parotid glands (Figure 1a ; 2921 ± 263 μl 10 min − 1 before IR vs 1170 ± 130 μl 10 min − 1 16 weeks after IR, P o0.01). Similarly, 16 weeks after receiving 9 Gy per day, there was an~75% reduction in the parotid salivary flow rate in the targeted glands ( Figure 1a ; 2915 ± 275 vs 720 ± 82 μl 10 min − 1 , P o0.01). Local parotid blood flow measurements began to decrease within~3 days after the start of fractionated IR (both IR dosing regimens). Parotid blood flows reached their nadir (~50% reduction) at 2 weeks post-IR and remained at this low level afterwards (Figure 1b) . There was no difference in the local blood flow rates between animals in the two IR dosing groups. Importantly, there was no significant variation in parotid blood flow rates in the control group animals over the entire time course of this study (Figure 1b ).
There was a significant decrease (nearly 50%) in the gross weight of irradiated parotid glands at 16 weeks, compared with those from non-IR (0 Gy) animals ( Figure 1c) . Thus, 16 weeks after receiving 7.5 Gy per day fractionated doses, gland weights were Figure 1 . Salivary and blood flow rates, gland weight and morphology in parotid glands of minipigs after fractionated IR. (a) Parotid saliva flow rates were obtained from the targeted parotid glands, or from control glands, as described in Materials and methods. One-way ANOVA was performed to determine statistical significance. By 16 weeks there was an~60% reduction in the targeted parotid flow rate in the 7.5 Gy group (Po 0.01), whereas in the 9 Gy group, there was an~75% reduction (P o0.01). Data shown are the mean values ± s.d. of parotid salivary output (μl 10 min 20.7 ± 0.9 g per gland, whereas those for glands from non-IR animals were 37.6 ± 1.0. Similarly, gland weights for 9 Gy per day dosing group were reduced to 18.8 ± 0.7 g per gland (both IR dosing groups P o0.001). There also was a small, but significant, difference in the final gland weights between animals treated with 7.5 or 9 Gy per day doses (at 16 weeks; P = 0.033). Finally, there was no change in the weights of the contralateral glands 16 weeks after IR (7.5 Gy per day, 37.9 ± 1.7 g per gland; 9 Gy per day, 36.9 ± 1.1 g per gland).
At the end of fractionated IR, all control glands were characterized by the presence of dense homogeneous clusters of serous secretory acini with eosinophilic cytoplasm and many translucent vacuoles (Figure 1d ). Conversely, all irradiated glands, treated either with 7.5 or 9 Gy, showed a reduction of acinar size and number, less eosinophilic staining in the acinar cell cytoplasm, an increase in adipose tissue and a marked increase in interstitial fibrosis; all indicating atrophy and degeneration of parenchymal cells (Figure 1d ; compare the hematoxylin and eosin staining, and the Masson's trichrome staining, in sections from all three study groups). Several ducts were dilated and contained cellular debris and inspissated secretions. Additionally, there was a marked reduction in the levels of immunoreactive aquaporin-5 detected in the acinar and intercalated duct cell region following both IR regimens.
There were no clinically significant differences in serum chemistry and hematology parameters after fractionated IR delivery to parotid glands of minipigs (data not shown). As shown in Table 1 , there were some modest but significant alterations in parotid salivary chemistry at 16 weeks after fractionated IR. For example, at 16 weeks post-IR, salivary potassium was significantly increased~15% in both the 7.5-and 9-Gy groups, whereas levels of salivary amylase and calcium secreted from the targeted glands were significantly decreased in both IR groups (~30-40%). No significant changes were found in the other measured salivary constituents or in salivary chemistry results for the contralateral glands (data not shown).
Effect of AdLTR 2 EF1α-FGF2 delivery Six minipigs were selected and randomly divided into two groups (n = 3 per group). One group received AdLTR 2 EF1α-FGF2 delivery to their parotid glands, whereas the other group served as a naive control. Animals were killed on day 7, and samples of parotid glands, serum and saliva were collected from both groups. Higher FGF2 levels were found in parotid gland extracts from the minipigs treated with AdLTR 2 EF1α-FGF2 (P o 0.05; Figure 2a) . However, no changes in FGF2 levels were detected in saliva and serum following vector delivery (Figures 2b and c) .
Next, we directly tested whether preadministration of AdLTR 2 EF1α-FGF2 could decrease the IR-induced reduction in MVD in minipig parotid glands. As there is an~60% reduction in the salivary flow rate at 7.5 Gy per day doses, to reduce animal morbidity we investigated whether parotid microvascular endothelial cells are targets for 7.5 Gy per day fractionated IR damage. Twelve minipigs were selected and randomly divided into three groups (n = 4 per group). Different groups received either no treatment (naive), the irrelevant control vector AdLacZ or AdLTR 2 EF1α-FGF2; administration was delivered to both parotid glands 48 h before IR and then MVD was assessed 24 h after IR (Figure 3) . MVD was markedly reduced 24 h after fractionated IR in parotid glands of minipigs treated with the control AdLacZ vector (Figures 3b and e) ; however, in animals treated with AdLTR 2 EF1α-FGF2 MVD remained high (Figures 3c and f, P o0.001) . Compared with naive group, the MVD of AdLTR 2 EF1α-FGF2-treated group was not significantly different (Figures 3g and h ).
Finally, we tested whether AdLTR 2 EF1α-FGF2-induced protection of MVD in salivary glands was associated with the maintenance of saliva production in irradiated minipigs. Twelve minipigs were selected and randomly divided into four groups (n = 3 per group). We administered vectors to the parotid glands of minipigs 48 h before IR and evaluated salivary flow 8 weeks after IR. Salivary flow rates of the IR and AdLacZ+IR groups declined rapidly 2 weeks after IR, but little change in salivary flow occurred in the AdLTR 2 EF1α-FGF2+IR group. Compared with the IR and AdLacZ+IR groups, the salivary flow rates of AdLTR 2 EF1α-FGF2 +IR group were significantly higher (P o0.001), and changed only slightly from that of naive animals ( Figure 4a ). Next, we tested whether FGF2 expression occurred until the end (8 weeks) of this experiment. We found that elevated FGF2 could be detected in parotid glands of minipigs treated with AdLTR 2 EF1α-FGF2+IR group at 8 weeks after IR (compared with AdLacZ+IR group: Po 0.05; compared with naive or IR group, Po 0.01) (Figure 4b ). LacZ expression (as a reporter gene) also was detected in parotid gland duct epithelium 8 weeks after irradiation in the AdLacZtreated group (Figures 4c and d) .
DISCUSSION
In the present study, we used two fractionated IR regimens (7.5 or 9 Gy per day for five consecutive days) and showed that minipig parotid salivary flow rates were markedly reduced by 16 weeks post-IR. Interestingly, we found that blood flow in the targeted parotid gland began to decrease~3 days after beginning IR, and by 2-weeks post-IR, it was reduced by 50%, and thereafter stabilized. The decreased local blood flow rate resulting from the fractionated IR occurred well before significant reductions were seen in salivary flow rates, and was greater in magnitude than that induced by a single IR dose in minipigs, as reported recently. 21 While the notion of microvascular endothelial cells being sensitive and important targets of IR is controversial, [22] [23] [24] [25] our present findings are consistent with this concept. 18, 19 Further, they support consideration of the local microvasculature as a potential target for preventing the significant quality of life sequelae that accompany IR-induced salivary hypofunction. (N = 4) . There were significant differences between the naive control group and the two IR groups for all parameters shown, as well as between the pre-IR and IR16W values for both IR groups. Data were analyzed by a repeated-measures ANOVA, followed by the Greenhouse-Geisser test. a Po 0.01.
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The two fractionated IR protocols, either 7.5 or 9 Gy per day for 5 days used herein, are not identical to the typical fractionated IR regimens used clinically. In devising these two IR schemes, we considered both the risk of frequent anesthesia use in experimental animals, as well as experimental timeframe, and concluded that the IR regimens used by us represent a reasonable compromise between animal safety and clinical modeling. Fractionated IR doses of 7.5 or 9 Gy per day for 5 days roughly equate to the delivery of total doses of 58 or 76 Gy, respectively, over 6-10 weeks (5 days per week) in 2 Gy fractions. The results from the present study showed that minipigs could tolerate parotid gland-localized, fractionated IR at these two doses without major untoward effects. Indeed, all animals remained generally healthy, exhibiting no significant changes in clinical chemistry and hematology parameters. According to our previous study, the dynamic changes in minipig parotid saliva flow rate occurred mainly by 16 weeks after single dose IR. 17 Herein, we also detected a relatively steady decline in saliva flow rate until 12-16 weeks post-IR. Accordingly, we tested whether delivery of the AdLTR 2 EF1α-FGF2 vector before IR could prevent IR-induced loss of parotid microvascular endothelial cells and could abrogate the IR-induced reduction in salivary flow. We chose this vector because the transduction of salivary glands by vectors with the AdLTR2EF1α backbone leads to much longer transgene expression compared with conventional Ad5 vectors. However, the immunogenicity of AdLTR2EF1α backbone vectors is similar with that of conventional vectors. 26 The functions of FGF2 include promoting mitosis and inducing the formation of new blood vessels, that is, FGF2 could be an appropriate survival factor for endothelium. Indeed, preadministration of AdLTR 2 EF1α-FGF2 prevented the IR-induced reduction in MVD in minipig parotid glands within 24 h after IR. These results are consistent with our previous findings in mice. 18 Furthermore, preadministration of AdLTR 2 EF1α-FGF2 also led to significantly higher levels of salivary secretion than seen with untreated but irradiated minipigs and with minipigs that were irradiated and administered a control vector. This too is consistent with our previous findings in mice, and represents a substantial extension of the earlier findings, that is, scalability to a large animal.
IR-induced damage to human major salivary glands was first described at the beginning of last century, yet its precise underlying mechanism is still somewhat enigmatic. 27, 28 Numerous animal studies have examined the morphologic and functional changes occurring in salivary glands after different radiation dose protocols in many species (e.g., mouse, rat, rabbit, nonhuman primate, minipigs). 14, 18, [29] [30] [31] [32] [33] At present, there are two accepted hypotheses to explain this enigma. One suggests the occurrence of lethal radiation effects in cells, possibly due to cell membrane disruption, 34, 35 whereas another suggests that hypofunction might be due to sublethal DNA damage in these cells with subsequent cell death by apoptosis. 36, 37 Our data support an emerging concept that salivary microvascular endothelial cells could be early targets of IR.
In summary, the present study demonstrates significant structural and functional sequelae of fractionated IR in parotid glands of the minipig. Using this model, we confirmed the previous observation in mice that prevention of IR-induced loss of microvascular endothelial cells in salivary glands is associated with a reduction in salivary hypofunction. Thus, the present findings support further study of the notion that a local treatment for protecting salivary gland endothelial cells may be beneficial for patients undergoing IR for head and neck cancer.
MATERIALS AND METHODS Animals
Healthy littermate male minipigs,~8 months old, weighing 28-35 kg, were obtained from the Institute of Animal Science of the Chinese Agriculture University (Beijing, China). Animals were kept under conventional conditions with free access to water and food. Food stock (200-250 g, mixed with water) was provided two times daily at 0830 hours and 1700 hours. This study was reviewed and approved by the Animal Care and Use Committee of Capital Medical University.
Fractionated irradiation on parotid glands in the miniature pig Before all experimental procedures, minipigs were anesthetized with an intramuscular injection of a combination of ketamine chloride (6 mg kg − 1 ) and xylazine (0.6 mg kg − 1 ). We performed computerized tomographic scans in the axial cut to determine the IR plan using a three-dimensional treatment planning system (Pinnacle3, version 7.6; ADAC Inc., Concord, CA, USA). Calculations showed that more than 95% of the radiation dose covered the whole target volume of the parotid gland. The reference point for all dose calculations was the center of the targeted parotid gland. Fractionated doses of 7.5 or 9 Gy for 5 days were used. We used source-toaxis distance technology in the IR group, with GA = 340°and GA = 155°for the two fields, respectively. The radiation field size (non-symmetrical field structure) for each group was the same at 12 × 10 cm 2 . A 95 cm source-toskin distance, including one parotid gland, was defined using an X-ray simulator for each minipig and the margins tattooed on the skin for the The calculated biologic effective dose of the 7.5 or 9 Gy regimens for 5 days was equal to a conventional clinical fractionated IR scheme of 58 or 76 Gy, in 29 or 38 fractions of 2 Gy per day, respectively. The dose-volume histogram for parotid glands was calculated using Pinnacle3, Version (7.6; ADAC Inc.). The control group of minipigs was anesthetized at the same time, but received no IR.
Ad5 vector preparation and administration
The AdLTR2EF1α-FGF2 vector was a hybrid vector, which included a modified Ad5 genome plus two DNA fragments from Moloney murine leukemia virus outside the expression cassette. 26 In the expression cassette, the human EF1α promoter drove the expression of FGF2, followed thereafter by the SV40 poly-A sequence. The recombinant vector AdLTR 2 EF1α-FGF2 was generated by homologous recombination of pACLTR 2 EF1α-FGF2 with pJM17 in C7 cells. AdLacZ was used as a vector control. AdLacZ was prepared exactly as described previously. 20 The titers (particles per ml) of purified vectors were determined by quantitative PCR using primers from the E2 region.
Vectors (AdLTR 2 EF1α-FGF2 or AdLacZ) were administrated 48 h before IR. After anesthesia of animals, cannulae were inserted approximately 3 cm into the orifice of the duct. Vectors were suspended in 0.9% NaCl (pH 7. 
Collection of saliva and blood
Parotid saliva was collected, and salivary flow rates determined, as described previously, using a modified Carlson-Crittenden cup on anesthetized animals following an intramuscular injection of pilocarpine (0.1 mg kg − 1 ). 17, 18 The collection device was identical to that used clinically in collecting parotid saliva from children and adolescents (9 mm inner ring diameter; 16 mm outer ring diameter). However, in this study, we used a mechanical vacuum device (Shanghai Zhang Dong Medical, Shanghai, China), instead of a rubber bulb, to hold the Carlson-Crittenden cup against the buccal mucosa. This provided a more stable and reproducible vacuum for keeping the parotid collecting device in place. Parotid saliva was collected from each parotid gland of all animals for~10 min on the days indicated in the Results section. Blood was obtained from the precaval vein at the same time points.
Local blood flow rate measurement Blood flow rate was measured for the targeted parotid gland after saliva collection. In the parotid gland area, we made three, aseptic 2.5-mm deep holes randomly using an epidural anesthesia needle. Thereafter, local blood flow rate was measured aseptically using a 3 mm in diameter laser Clinical laboratory analyses with blood and saliva samples 
Histologic and immunocytochemical analyses
After killing at 16 weeks post-IR, parotid glands from both the irradiated and contralateral sides were carefully dissected, cleaned of extraneous tissue and weighed. Thereafter, glands were cut into multiple pieces (~5 × 5 × 5 mm 
